AIV Logo AIV Assistant

 Logo Aclarion Inc. Common Stock - ACON 7.44 USD

EPS
-2.40
ROE
-714.18
Beta
0.40

7.440 USD

7.440 USD

Daily: +0.00%
Key Metrics

EPS: -2.40

Book Value: -0.88

Debt/Equity: 47.32

% Insiders: 9.768%

Growth

Revenue Growth: -0.36%

Estimates

Forward P/E: -0.19

Forward EPS: -0.54

 Logo About Aclarion Inc. Common Stock - (ACON)

Country: United States

Sector: Information Technology

Website: nan

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

Exchange Ticker
NMS (United States) ACON

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
Jan. 4, 2024 0.06
Jan. 30, 2025 0.00
Jan. 29, 2025 0.00
March 28, 2025 0.04
Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion